Feb 26 2010
NextBio, developer of an innovative software platform that enables life
science researchers to search, discover, and share knowledge locked
within public and proprietary data, today announced a license agreement
with global biopharmaceutical company UCB, for NextBio Enterprise.
NextBio Enterprise offers life sciences organizations unique tools for
knowledge discovery and collaboration, seamless integration of internal
and external research data, and secure data access.
“UCB is one of the leading biopharmaceutical companies, with operations
in Europe, the United States and Asia”
“UCB is one of the leading biopharmaceutical companies, with operations
in Europe, the United States and Asia,” said Saeid Akhtari, co-founder
and Chief Executive Officer of NextBio. “We are very pleased that they
are adopting the Enterprise version of the NextBio platform as an
integral part of their research and development efforts. UCB’s adoption
of NextBio Enterprise will enable its scientists to gain unique insights
from data created by diverse high-throughput technologies.”
Research shows GLP-1 drugs safeguard vision despite small retinopathy risk